| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3085869
Max Phase: Preclinical
Molecular Formula: C13H16N4OS
Molecular Weight: 276.37
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cn1cccc1C(=O)N[C@H]1CCc2nc(N)sc2C1
Standard InChI: InChI=1S/C13H16N4OS/c1-17-6-2-3-10(17)12(18)15-8-4-5-9-11(7-8)19-13(14)16-9/h2-3,6,8H,4-5,7H2,1H3,(H2,14,16)(H,15,18)/t8-/m0/s1
Standard InChI Key: JNFQGNNJCPRLFH-QMMMGPOBSA-N
Associated Targets(Human)
Sodium channel protein type V alpha subunit 3462 Activities
Sodium channel protein type IX alpha subunit 8393 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Sodium channel protein type IV alpha subunit 583 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Sodium channel protein type III alpha subunit 275 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HepG2 196354 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 276.37 | Molecular Weight (Monoisotopic): 276.1045 | AlogP: 1.35 | #Rotatable Bonds: 2 |
| Polar Surface Area: 72.94 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.47 | CX LogP: 1.35 | CX LogD: 1.35 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.87 | Np Likeness Score: -1.98 |
References
| 1. Hodnik Ž, Tomašić T, Mašič LP, Chan F, Kirby RW, Madge DJ, Kikelj D.. (2013) Novel state-dependent voltage-gated sodium channel modulators, based on marine alkaloids from Agelas sponges., 70 [PMID:24148992] [10.1016/j.ejmech.2013.07.034] |
| 2. Tomasic T, Nabergoj D, Vrbek S, Zidar N, Jakopin Z, Zula A, Hodnik Z, Jukic M, Anderluh M, Ilas J, Dolenc MS, Peluso J, Ubeaud-Sequier G, Muller CD, Masic LP, Kikelj D. (2015) Analogues of the marine alkaloids oroidin, clathrodin, and hymenidin induce apoptosis in human HepG2 and THP-1 cancer cells, 6 (1): [10.1039/C4MD00286E] |
Source
Source(1):